Dopaquinone and related compounds: reactions with o phenylenediamine

DOI: 10.1246/bcsj.47.1957

Source and publish data:

Bulletin of the Chemical Society of Japan p. 1957 - 1959 (1974)

Update date:2022-07-29

Topics:

Authors:

Omote Omote

Hirama Hirama

Komatsu Komatsu

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1246/bcsj.47.1957

Full text of DOI:10.1246/bcsj.47.1957

Products guided by the article

Product name:2-benzoylamino-3-phenazin-2-yl-propionic acid methyl ester

Cas No:54296-22-9

R&D Labs maybe for 54296-22-9

Hangzhou Showland Technology Co., Ltd.

Contact:86-571-88920516

Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Tocopharm Co., Ltd.

Contact:+86-021-6989-5597

Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Jingzhou TianHe Sci&Tech Chemical Co., Ltd.

Contact:86-716-8331612

Address:Jiangjin Road, #18, High-grade technology industries development district, Jingzhou city, Hubei province
Onlychem (Jinan)Biotech Co.,Ltd

Contact:86-531-83175885

Address:No. 44, Honglou South Road, Jinan,China
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd

Contact:+86-517-86283327

Address:9 North Hantai Road, Huaian, China

Relevant to this article

Scouting human A₃ adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study

Doi:10.1021/jm070852a
(2007)
Unexpected tosyl deprotection during osmium catalysed dihydroxylation

Doi:10.1016/j.tetlet.2007.11.058
(2008)
Syntheses, structures and redox properties of some complexes containing the Os(dppe)Cp* fragment, including [{Os(dppe)Cp*}₂(μ- CCCC)]

Doi:10.1039/b712104k
(2007)
Strong inhibition of cholera toxin binding by galactose dendrimers

Doi:10.1039/b711070g
(2007)
Blue emitters based on Anthracene-Aryl-Anthracene moieties end-capped with 1-naphthyl groups for organic light-emitting diodes

Doi:10.1166/jnn.2015.10392
(2015)
Application of spectrophotometric, densitometric, and HPLC techniques as stability indicating methods for determination of Zaleplon in pharmaceutical preparations

Doi:10.1016/j.saa.2007.01.024
(2007)

Article Doi